Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-021182
Filing Date
2022-02-14
Accepted
2022-02-14 06:19:19
Documents
1
Group Members
ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226482d3_sc13g.htm SC 13G 72999
  Complete submission text file 0001104659-22-021182.txt   74520
Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Filed by) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: SC 13G

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Subject) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93025 | Film No.: 22624670
SIC: 2834 Pharmaceutical Preparations